Taxifolin Market Poised for Robust Growth & Unprecedented Demand by 2031 | Ametis JSC, Kalenika Group, ROBIOS

Los Angeles, United States - QY Research has unveiled its latest study titled "Global Taxifolin Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031." This newly released report delivers a comprehensive overview of the global Taxifolin market, analyzing the forces shaping its growth trajectory and providing valuable insights for stakeholders, investors, and industry professionals. the research covers key areas including market dynamics, segmentation, regional performance, competitive landscape, and emerging technology trends that are redefining industry standards. Backed by reliable data and expert analysis, the report serves as a trusted guide to understanding both microeconomic and macroeconomic factors driving market evolution.

The global market for Taxifolin was estimated to be worth US$ 26.00 million in 2024 and is forecast to a readjusted size of US$ 38.18 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.

Download Free Sample PDF Report (with full TOC, tables, and charts) To Explore Detailed Insights and Forecasts @ https://qyresearch.in/request-sample/chemical-material-global-taxifolin-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Taxifolin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global taxifolin sales will reach 20,000 kg, with an average selling price of approximately US$1,300/kg.Taxifolin, also known as dihydroquercetin, is a natural flavonoid found in plants as diverse as Siberian larch, milk thistle, and onion. It is known for its potent antioxidant, anti-inflammatory, and anti-aging properties, making it a popular ingredient in dietary supplements and skincare products. Taxifolin is structurally similar to the well-known flavonoid quercetin, but boasts greater water solubility and stability, enhancing its bioavailability and therapeutic potential. Research suggests it may support cardiovascular health, improve immune function, and protect cells from oxidative stress.

Global key taxifolin players include Ametis, ROBIOS and JW Health Products etc. The top 3 companies hold a share about 96%. Asia-Pacific is the largest market with a share about 34%, followed by Europe and America. In terms of product, the product whose purity is below 92% is the largest segment with a share about 72%. And in terms of applications, the largest application is healthcare with a share about 40%.

Competitive Landscape: -

Ametis JSC
Jilin Jianwei Natural Biotechnology
Kalenika Group
ROBIOS
Xi'an Sost Biotech Co.,Ltd
Focusherb
Hoycome
Herbchem Biotech

The competitive landscape is a must-have information for the market players to withstand the competition present in the global Taxifolin market. This further helps the market participants to develop effective strategies to optimize their market positions. Moreover, the competitive analysis helps them to determine potential advantages as well as barriers within the global Taxifolin market. This way, they can monitor how their competitors are implementing various strategies including pricing, marketing, and distribution.

The main drivers of the taxusin market include the following: -

1. Explosive demand in the pharmaceutical sector and expansion of clinical applications

1. Expansion of core ingredients and indications for anticancer drugs

Significant anticancer effects: Taxusin, a natural anticancer active ingredient, is highly effective in treating solid tumors such as breast and ovarian cancer. The global market size is expected to reach US$920 million in 2023, with China accounting for 28%. Targeted drug development is accelerating, with the number of clinical trials for indications such as lung and gastric cancer increasing 3.2-fold compared to 2020. It is expected that these drugs will contribute an incremental market share of 800 million to 1 billion yuan in 2025.

Policy support and medical insurance coverage: The National Medical Products Administration's "Technical Guidelines for Priority Review of Anticancer Drugs" has fast-tracked taxusin compound preparations, shortening the approval cycle to 180 working days. Dynamic adjustments to the medical insurance catalog have increased the reimbursement rate for paclitaxel-based drugs from 65% to 82%, reducing annual treatment costs for patients to 32,000 to 48,000 yuan, significantly improving drug accessibility. 2. Formulation Technology Innovation and R&D Investment

New Drug Delivery Systems: New drug delivery methods such as liposome delivery systems and nanocrystal technology have increased bioavailability by 40%-60% and reduced drug toxicity and side effects by approximately 30%.

II. Consumption Upgrade in the Health Products and Cosmetics Market

1. Surge in Demand for Natural Antioxidants

Rising Health Awareness: Global awareness of chronic diseases and oxidative stress-related conditions is increasing, driving consumer demand for natural antioxidants and health supplements.

Functional Foods and Agricultural Applications

2. Efficacy Breakthroughs in Cosmetics

Anti-Aging and Whitening Effects: Taxifolin at a concentration of 0.5% can increase skin elasticity by 27% and reduce wrinkle depth by 33% for eight weeks. It also non-competitively inhibits tyrosinase activity, surpassing arbutin in effectiveness.

High-End Brand Applications: Brands such as Proya use it as a core ingredient, driving price premiums of 300%-500% for related products. Medical dressings are used for post-laser surgery repair, reducing erythema and hyperpigmentation. III. Technological Advances and Cost Optimization Drive Industrialization

1. Extraction Technology Breakthroughs and Environmental Compliance

Supercritical CO2 Extraction Technology: The penetration rate will increase from 18% in 2020 to 43% in 2025, with residual solvent levels reduced to below 0.02 ppm. The number of companies meeting European and American cGMP standards will increase by 300%.

Synthetic Biology and Cell Culture: Chemical synthesis (semi-synthesis and total synthesis) has become the mainstream preparation method due to its low cost and high yield. A listed company's 50-ton bioreactor production line has increased extraction efficiency by 12-fold and reduced single-cycle production costs by 58%.

2. Raw Material Supply and Sustainable Development

Expansion of Artificial Planting Bases: Wild yew resources are limited, and the area of artificial planting is expanding at an average annual rate of 24%, reaching 128,000 mu in 2023. Yunnan and Sichuan will together contribute 65% of the national raw material supply. Construction of the "10,000 Mu Yew GAP Base" project has commenced, with an expected raw material self-sufficiency rate of 70% by 2027. Driven by environmental policies: Supercritical CO2 extraction technology reduces solvent pollution, aligns with sustainable development requirements, and promotes the industry's transition to green manufacturing.

The taxifolin market is experiencing rapid growth driven by explosive demand in the pharmaceutical sector, rising consumption of health supplements and cosmetics, and technological advancements and cost optimization.

Regional Insights -

The report takes readers on a journey through four key regions: United States, Asia-Pacific, and EMEA. Key nations like the United States, Germany, the United Kingdom, China, Japan, South Korea, and more are thoroughly examined. The data is presented in a timeline from 2024 as the base year, with projections extending to 2031.

North America: United States, Canada, Mexico

Latin America: Brazil and other key markets

Asia Pacific: China, Japan, South Korea, India, ASEAN countries

Europe, Middle East & Africa (EMEA): Major European economies, GCC countries, and African nations

The report provides a region-wise breakdown of market share, consumption trends, and future prospects.

Detailed of Taxifolin Market Segmentation -

The report offers great insights into important segments of the global Taxifolin market while concentrating on their CAGR, market size, market share, and future growth potential. The global Taxifolin market is mainly segmented according to type of product, application, and region. Each segment in these categories is extensively researched to become familiar with their growth prospects and key trends. Segmental analysis is highly important to identify key growth pockets of a global market. The report provides specific information on the market growth and demand of different products and applications to help players to focus on profitable areas of the global Taxifolin market.

Segmentation By Type :-

Below 92%
92%-98%
Above 98%

Segmentation By Application -

Food and Beverages
Healthcare
Cosmetics
Agriculture
Others

This segmentation helps identify high-growth opportunities and niche segments for investors and businesses.

Request for Pre-Order Enquiry On This Exclusive Report @ https://qyresearch.in/pre-order-inquiry/chemical-material-global-taxifolin-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Why This Report is a Must-Have -

ᗒ Historical Analysis (2020-2024) & Forecasts (2025-2031): Gain a clear understanding of market trends and future growth potential.

ᗒ Comprehensive Market Segmentation: Detailed breakdown by Type, Application, and Region to identify lucrative opportunities.

ᗒ Competitive Landscape: Insights into key players, their market share, and strategic developments like mergers, acquisitions, and expansion plans.

ᗒ Drivers & Restraints: Understand the factors shaping the market's growth and the challenges that could impact your strategy.

ᗒ Expert Opinions & Market Dynamics: Benefit from expert analysis to navigate market risks and capitalize on emerging trends.

Taxifolin Market Report Objectives -

(1) Analyzing the size of the global Taxifolin market on the basis of value and volume

(2) Accurately calculating the market shares, consumption, and other vital factors of different segments of the global Taxifolin market

(3) Exploring key dynamics of the global Taxifolin market

(4) Highlighting important trends of the global Taxifolin market in terms of production, revenue, and sales

(5) Deeply profiling top players of the global Taxifolin market and showing how they compete in the industry

(6) Studying manufacturing processes and costs, product pricing, and various trends related to them

(7) Showing the performance of different regions and countries in the global Taxifolin market

(8) Forecasting the market size and share of all segments, regions, and the global market.

Important Questions Answered included in the Report:-

(A) What is the market size and growth rate of the global and regional market by various segments?

(B) What is the market size and growth rate of the market for selective Countries?

(C) Which region or sub-segment is expected to drive the market in the forecast period?

(D) What factors are estimated to drive and restrain the market growth?

(E) What are the key technology and market trends shaping the market?

(F) what are the key opportunity in the market?

(G) Who are the leading manufacturers operating in the global Taxifolin market?

(H) Which key player accounted for the highest market share?

(I) What are the growth opportunities for the new entrants in the global Taxifolin market?

Table of Contents - Major Key Points:

1 Market Overview
1.1 Taxifolin Product Introduction
1.2 Global Taxifolin Market Size Forecast
1.2.1 Global Taxifolin Sales Value (2020-2031)
1.2.2 Global Taxifolin Sales Volume (2020-2031)
1.2.3 Global Taxifolin Sales Price (2020-2031)
1.3 Taxifolin Market Trends & Drivers
1.3.1 Taxifolin Industry Trends
1.3.2 Taxifolin Market Drivers & Opportunity
1.3.3 Taxifolin Market Challenges
1.3.4 Taxifolin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Taxifolin Players Revenue Ranking (2024)
2.2 Global Taxifolin Revenue by Company (2020-2025)
2.3 Global Taxifolin Players Sales Volume Ranking (2024)
2.4 Global Taxifolin Sales Volume by Company Players (2020-2025)
2.5 Global Taxifolin Average Price by Company (2020-2025)
2.6 Key Manufacturers Taxifolin Manufacturing Base and Headquarters
2.7 Key Manufacturers Taxifolin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Taxifolin
2.9 Taxifolin Market Competitive Analysis
2.9.1 Taxifolin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Taxifolin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taxifolin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Below 92%
3.1.2 92%-98%
3.1.3 Above 98%
3.2 Global Taxifolin Sales Value by Type
3.2.1 Global Taxifolin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Taxifolin Sales Value, by Type (2020-2031)
3.2.3 Global Taxifolin Sales Value, by Type (%) (2020-2031)
3.3 Global Taxifolin Sales Volume by Type
3.3.1 Global Taxifolin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Taxifolin Sales Volume, by Type (2020-2031)
3.3.3 Global Taxifolin Sales Volume, by Type (%) (2020-2031)
3.4 Global Taxifolin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food and Beverages
4.1.2 Healthcare
4.1.3 Cosmetics
4.1.4 Agriculture
4.1.5 Others
4.2 Global Taxifolin Sales Value by Application
4.2.1 Global Taxifolin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Taxifolin Sales Value, by Application (2020-2031)
4.2.3 Global Taxifolin Sales Value, by Application (%) (2020-2031)
4.3 Global Taxifolin Sales Volume by Application
4.3.1 Global Taxifolin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Taxifolin Sales Volume, by Application (2020-2031)
4.3.3 Global Taxifolin Sales Volume, by Application (%) (2020-2031)
4.4 Global Taxifolin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Taxifolin Sales Value by Region
5.1.1 Global Taxifolin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Taxifolin Sales Value by Region (2020-2025)
5.1.3 Global Taxifolin Sales Value by Region (2026-2031)
5.1.4 Global Taxifolin Sales Value by Region (%), (2020-2031)
5.2 Global Taxifolin Sales Volume by Region
5.2.1 Global Taxifolin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Taxifolin Sales Volume by Region (2020-2025)
5.2.3 Global Taxifolin Sales Volume by Region (2026-2031)
5.2.4 Global Taxifolin Sales Volume by Region (%), (2020-2031)
5.3 Global Taxifolin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Taxifolin Sales Value, 2020-2031
5.4.2 North America Taxifolin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Taxifolin Sales Value, 2020-2031
5.5.2 Europe Taxifolin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Taxifolin Sales Value, 2020-2031
5.6.2 Asia Pacific Taxifolin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Taxifolin Sales Value, 2020-2031
5.7.2 South America Taxifolin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Taxifolin Sales Value, 2020-2031
5.8.2 Middle East & Africa Taxifolin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Taxifolin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Taxifolin Sales Value and Sales Volume
6.2.1 Key Countries/Regions Taxifolin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Taxifolin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Taxifolin Sales Value, 2020-2031
6.3.2 United States Taxifolin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Taxifolin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Taxifolin Sales Value, 2020-2031
6.4.2 Europe Taxifolin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Taxifolin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Taxifolin Sales Value, 2020-2031
6.5.2 China Taxifolin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Taxifolin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Taxifolin Sales Value, 2020-2031
6.6.2 Japan Taxifolin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Taxifolin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Taxifolin Sales Value, 2020-2031
6.7.2 South Korea Taxifolin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Taxifolin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Taxifolin Sales Value, 2020-2031
6.8.2 Southeast Asia Taxifolin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Taxifolin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Taxifolin Sales Value, 2020-2031
6.9.2 India Taxifolin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Taxifolin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Ametis JSC
7.1.1 Ametis JSC Company Information
7.1.2 Ametis JSC Introduction and Business Overview
7.1.3 Ametis JSC Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Ametis JSC Taxifolin Product Offerings
7.1.5 Ametis JSC Recent Development
7.2 Jilin Jianwei Natural Biotechnology
7.2.1 Jilin Jianwei Natural Biotechnology Company Information
7.2.2 Jilin Jianwei Natural Biotechnology Introduction and Business Overview
7.2.3 Jilin Jianwei Natural Biotechnology Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Jilin Jianwei Natural Biotechnology Taxifolin Product Offerings
7.2.5 Jilin Jianwei Natural Biotechnology Recent Development
7.3 Kalenika Group
7.3.1 Kalenika Group Company Information
7.3.2 Kalenika Group Introduction and Business Overview
7.3.3 Kalenika Group Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Kalenika Group Taxifolin Product Offerings
7.3.5 Kalenika Group Recent Development
7.4 ROBIOS
7.4.1 ROBIOS Company Information
7.4.2 ROBIOS Introduction and Business Overview
7.4.3 ROBIOS Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 ROBIOS Taxifolin Product Offerings
7.4.5 ROBIOS Recent Development
7.5 Xi'an Sost Biotech Co.,Ltd
7.5.1 Xi'an Sost Biotech Co.,Ltd Company Information
7.5.2 Xi'an Sost Biotech Co.,Ltd Introduction and Business Overview
7.5.3 Xi'an Sost Biotech Co.,Ltd Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Xi'an Sost Biotech Co.,Ltd Taxifolin Product Offerings
7.5.5 Xi'an Sost Biotech Co.,Ltd Recent Development
7.6 Focusherb
7.6.1 Focusherb Company Information
7.6.2 Focusherb Introduction and Business Overview
7.6.3 Focusherb Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Focusherb Taxifolin Product Offerings
7.6.5 Focusherb Recent Development
7.7 Hoycome
7.7.1 Hoycome Company Information
7.7.2 Hoycome Introduction and Business Overview
7.7.3 Hoycome Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hoycome Taxifolin Product Offerings
7.7.5 Hoycome Recent Development
7.8 Herbchem Biotech
7.8.1 Herbchem Biotech Company Information
7.8.2 Herbchem Biotech Introduction and Business Overview
7.8.3 Herbchem Biotech Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Herbchem Biotech Taxifolin Product Offerings
7.8.5 Herbchem Biotech Recent Development
8 Industry Chain Analysis
8.1 Taxifolin Industrial Chain
8.2 Taxifolin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Taxifolin Sales Model
8.5.2 Sales Channel
8.5.3 Taxifolin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.